Lyme Borreliosis

Lancet Infect Dis. 2004 Apr;4(4):197-8; discussion 198-9. doi: 10.1016/S1473-3099(04)00965-X.

Publication types

  • Comment

MeSH terms

  • Animals
  • Anti-Bacterial Agents / therapeutic use*
  • Borrelia burgdorferi Group / genetics
  • Borrelia burgdorferi Group / pathogenicity*
  • Disease Reservoirs
  • Europe / epidemiology
  • Humans
  • Ixodes / growth & development*
  • Ixodes / microbiology
  • Lyme Disease* / drug therapy
  • Lyme Disease* / epidemiology
  • Lyme Disease* / physiopathology
  • United States / epidemiology

Substances

  • Anti-Bacterial Agents